Liu B, Zheng Y, Yin F, Yu J, Silverman N, Pan D. Toll Receptor-Mediated Hippo Signaling Controls Innate Immunity in Drosophila. Cell. 2016 Jan28;164(3):406-19.
Yin F, Yu J, Zheng Y, Chen Q, Zhang N, Pan D. Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell. 2013 Sep 12;154(6):1342-55.
Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, AndersRA, Maitra A, Pan D. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 2007 Sep 21;130(6):1120-33.
Huang J, Wu S, Barrera J, Matthews K, Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell. 2005 Aug 12;122(3):421-34.
Wu S, Huang J, Dong J, Pan D. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell. 2003 Aug 22;114(4):445-56.
Cai J, Song X, Wang W, Watnick T, Pei Y, Qian F, Pan D. A RhoA-YAP-c-Myc signaling axis promotes the development of polycystic kidney disease. Genes Dev. 2018 Jun 1;32(11-12):781-793.
學術交流
2010年—2016年11月,潘多加在全球受邀做學術報告72場(其中9場作為特邀主講人)。
專利成果
截至2016年7月,潘多加獲得專利3項。
專利名稱
專利號
New KUZ polypeptides, members of the ADAM family of metalloprotease - useful in neural partitioning and development
-
Modulating angiogenesis in a vertebrate animal involves specifically modulating the activity of Drosophila Kuzbanian in the animal
-
A Tumor Suppressor Designated Hippo
7556942
科研項目
項目名稱
項目周期
Control of organ size and tumorigenesis by the Hippo signaling pathway
2008年—2018年
Developing Molecular Targeted Therapies against NF2
2014年—2017年
Hippo Signaling in Polycystic Kidney Disease
2014年—2017年
Chemical probes targeting nuclear effector complex of the Hippo signaling pathway
潘多加對基本細胞信號通路的見解對人們理解癌症細胞生長產生了重大影響(His insights into fundamental cell signaling pathways have had a major impact on our understanding of cancer growth.)。(時任約翰斯·霍普金斯大學醫學院分子生物學和遺傳學系主任Carol Greider博士評)